Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for postoperative bleeding after TURP
IRCT20251029067808N1Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Tadalafil with Placebo (2 arms). Started Dec 2025; status: recruiting.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20251029067808N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251029067808N1.